drugset / Trial / NCT00847483

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

NCT00847483

Phase 4 Completed 375 enrolled Viatris Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Compare the IOP lowering properties of latanoprost, travoprost and bimatoprost

Timeline

Start
2002-01
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimatoprost Other / unclassified 0.03 % Other
Comparator Latanoprost Small molecule 0.005 % Other
Comparator Travoprost Other / unclassified 4 % Other